To further determine the role of SALL2 in the response to tamoxifen treatment, the expression of SALL2 was assessed in 238 clinical breast cancer specimens, including 90 cases of tamoxifen‐treated breast cancer (Appendix Table S2). This evidence concerns the gene SALL2 and breast carcinoma.